| | | NEW YORK (Reuters) - Stocks tumbled on Wednesday as surging bond yields in Spain and Italy ratcheted up tensions in financial markets about Europe's ability to solve its growing debt crisis. | | | | SAN ANTONIO/NEW YORK (Reuters) - The Federal Reserve should not move to ease monetary policy any further, despite dim prospects that unemployment will fall sharply any time soon, two top Fed officials said on Wednesday. | | | | | | | TORONTO/NEW YORK (Reuters) - BlackBerry maker Research In Motion Ltd may be running out of options as it struggles to turn around its slumping fortunes with the help of a coterie of investment bankers. | | | | | | | NEW YORK (Reuters) - Oil dropped more than 3 percent on Wednesday to the lowest level in nearly six months as fears about the euro zone crisis sparked an erosion in risk appetite across markets. | | | | | FAYETTEVILLE, Arkansas (Reuters) - Top executives of Wal-Mart Stores Inc did not directly mention a Mexican bribery scandal at an employee pep rally on Wednesday, but asked their international workers to focus on "integrity" as a core value. | | | | | | | WASHINGTON (Reuters) - Contracts to purchase previously owned U.S. homes unexpectedly fell in April to a four-month low, undermining some of the recent optimism that the housing sector was touching bottom. | | | | | (Reuters) - After Bernard Madoff's fraud unraveled in late 2008, Yale Fishman was courted by Wall Street traders seeking to buy his claim to assets that could be recovered from the mess. After three years of ignoring their calls, he finally said yes. | | | | | | | DALLAS (Reuters) - Shareholders threw more support behind Exxon Mobil Corp's executive compensation package following the world's largest publicly traded oil company's effort to seek more input on the matter. | | | | SAN RAMON, California (Reuters) - Shareholders owning 27 percent of Chevron Corp voted for more disclosure on the risks to its operations and finances from both hydraulic fracturing regulation and growing public opposition to the oil and gas production practice. | | | | | | NEW YORK/LONDON (Reuters) - GlaxoSmithKline Plc plans to launch a campaign to replace the entire board of Human Genome Sciences Inc with its own nominees, stepping up its $2.6 billion hostile bid for the U.S. biotech company, sources familiar with the situation said on Wednesday. | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment